Webb4 jan. 2024 · Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is announcing a business arrangement with, and a strategic investment in, Heading Health, LLC (“Heading Health”), a psychiatric clinic platform focused on the administration of … Webb12 aug. 2024 · EEG Study to be incorporated into Entheon IQ(TM), developing data-driven treatment algorithms for psychedelic treatments Vancouver, British Columbia--(Newsfile …
Simon M. Tankel - Chevrolet Business Development Manager
Webb5 jan. 2024 · Überdies erkennt Entheon den bedeutenden Wert der Daten, die Heading erheben wird, um die Behandlungsergebnisse bei den Patienten zu verbessern", meint Simon Tankel, CEO von Heading... WebbSimon's Skills Investment Banking Marketing Strategy Sales Process Simon's Experience Heading Health • Co-Founder Fairhelper • Co-Founder Fairhelper makes it cheaper and … the soapworks salford
Austin Texas based Heading Health is raising ... - intelligence360
Webb4 jan. 2024 · Entheon Biomedical Corp. , a biotechnology company focused on developing psychedelic medicines to treat addiction, is announcing a business arrangement with, and a strategic investment in, Heading... March 24, 2024 Webb5 jan. 2024 · Entheon Biomedical kündigt Investition und Geschäftsvereinbarung mit Heading Health LLC an Vancouver BC 4. Januar 2024. Corp. CSE: „ENBI“ FWB: „1XU1“ „Entheon“ oder das „Unternehmen“ ein Biotechnologieunternehmen auf die Entwicklung psychedelischer Arzneimittel zur Behandlung WebbHeading. Healthcare Services · United States · <25 Employees . Heading is a company that operates in the Hospital & Health Care industry. It employs 6-10 people and has $1M … myra in family matters